Talking Urology Podcast

Cora Sternberg discusses prostate cancer heterogeneity and the exciting potential of molecular classification

Herbert Lepor discusses the good news on LUTS and sexual dysfunction following radical prostatectomy: the long game.

Jonathan Epstein discusses the critical role of pathological grading in determining men suitable active surveillance.

Peter Black discusses lessons learned from immunotherapy in bladder cancer and what we might need to look out for in prostate cancer.

Chris Sweeney discusses which is best? Abiraterone vs docetaxal with ADT for hormone naïve metastatic prostate cancer

Chris Sweeney discusses upfront combination therapy and immunotherapy in men with metastatic prostate cancer

Piet Ost discusses the STOMP trial and the benefits of metastasis directed therapy in oligometastatic disease

John Oliffe discusses the factors contributing to depression and suicidality in men with prostate cancer

A/Prof Nathan Lawrentschuk, USANZ 2017 convener, host of Talking Urology & Urological Surgeon & Urologic Oncologist.

Joseph discusses with Nathan highlights of USANZ 2017 and the emerging themes.

Talking Urology is proudly supported by Ipsen.

A/Prof Shankar Siva, Radiation Oncologist & NHMRC fellow at the Peter MacCallum Cancer Centre, Melbourne.

Shankar argues the case for metastasis directed therapy with Joseph in oligometastatic disease.

Talking Urology is proudly supported by Ipsen.